Determinants of medication adherence to Levothyroxine in pregnant women with Hypothyroidism
Keywords:
Pregnancy; hypothyroidism; Levothyroxine; medication adherenceAbstract
Objectives: Pregnant women with hypothyroidism require hormone replacement therapy with thyroxine. It is prudent to initiate prompt treatment of hypothyroidism to prevent adverse outcomes in both mother and the neonate. Non-adherence to medication is synonymous with treatment failure, it increases health care costs and may lead to poor quality of life. The aim of this study was to determine the factors contributing to non-adherence to levothyroxine in pregnant women.
Methods: This was a cross-sectional interventional study. Pregnant women >18 years of age, with hypothyroidism on levothyroxine for minimum 3 months were eligible for inclusion. Women with sub-clinical hypothyroidism and those on drugs likely to interfere with thyroxine were excluded.
Results: The study enrolled 75 patients with a mean age of 27.2±4.3 years. The mean duration of illness (hypothyroidism) was 26±30.6 (range, 2-120 months). The mean TSH levels were 3±1.4 (range, 1.1-5.7 milli-international/L). The mean dose of levothyroxine was 64.5±34.8 (range, 12.5-125 mcg). Fifty-three (70.7%) women were taking folic acid supplements and fifteen (20%) women were on alternative and complimentary medications. Morisky, Green and Levine (MGL) medication adherence scale was administered to eligible participants. The study revealed that 54.7% pregnant women with hypothyroidism have low to medium adherence to levothyroxine therapy. Multiple regression analysis revealed that patient’s age, education level and disease insight, gestational age, folic acid supplementation and cost of medication significantly (P<0.05) influenced adherence to levothyroxine in this cohort.
Conclusion; Patient’s age, educational status and disease insight, andmedication costs significantly influence adherence to medication in pregnancy women with hypothyroidism.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 International Journal of Pharmacological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article